Montelukast Sodium Market: How Is Neuropsychiatric Safety Reevaluation Becoming the Fastest-Growing Regulatory Driver?
Neuropsychiatric safety reevaluation of montelukast sodium — the FDA black box warning update in 2020 and ongoing pharmacovigilance investigations into suicidality, depression, and neuropsychiatric events associated with the leukotriene receptor antagonist representing the fastest-growing regulatory driver in the global montelukast market — creates the most clinically scrutinized...
0 Yorumlar 0 hisse senetleri 3 Views 0 önizleme
BuzzingAbout https://www.buzzingabout.com